Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Neoplasms 1Multiple Myeloma 1Mucositis 1Lymphoma 1Intraoperative Complications 1Head and Neck Neoplasms 1Chronic Pain 1Cancer Pain 1Abnormalities, Radiation-Induced 1

Interventions

Morphine 7Ketamine 5Fentanyl 4Sodium Chloride 3Saline Solution 3Lidocaine 3Educational Status 3Dexmedetomidine 3Cognitive Behavioral Therapy 3Anesthetics, Local 3Surveys and Questionnaires 2Pregabalin 2Mindfulness-Based Stress Reduction 2Hypnosis 2Bupivacaine 2Acetaminophen 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tianeptine 1siltuximab 1onabotulinum toxin A 1nabiximols 1morphine, naltrexone combination 1erenumab 1Yoga 1Waiting Lists 1Transcutaneous Electric Nerve Stimulation 1Tramadol 1Therapeutics 1Telemedicine 1Tea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chronic Pain × Pain Management × Clear all
NCT05877521 2025-09-23

Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
76 enrolled

Cancer Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡